• All
  • --
  • ---
  • -2022
  • 2022-2
  • 2022-2-2-2
  • 2022-deltia-tipoy
  • 2022-deltia-tipoy-2-2
  • 2022-deltia-tipoy-2-2-2-2
  • 2023-deltia-typou
  • 2023-deltia-typou-2-2
  • 2024
  • 257-2
  • 257-2-2-2
  • 266-2
  • Announcements
  • Announcements 2025
  • Consolidated Financial Results
  • deltia-tipoy
  • deltia-tipoy-2-2
  • deltia-tipoy-2-2-2-2
  • Distribution of Divident
  • Events
  • FAQ
  • General Meetings and Corporate Actions
  • Insiders Transactions Disclosures
  • Invitations
  • invitations-2
  • Presentations
  • Press Kits
  • Press Releases
  • Regulated Information
  • Results 2024
  • Share Capital Increase
  • Uncategorized

  A new year begins. 2012 is for us, at Lavipharm, the first year of the second century since our establishment. We continue our work with a clear vision, determination, will and persistence, focused to our goal for Innovation in Health. Season’s Greetings!...

This year, we are sending our holiday wishes through a child’s painting, created by Maria Koumoutsi. Maria, 9 years old, won the “100 years, countless wishes for 2011” competition organized by Lavipharm with the participation of employees’ children. With their pure and virtuous drawings children...

This year, we wish you happy holidays the “Lavipharm” way. This year’s holiday card is created for Lavipharm by Lavipharm. Many children of Lavipharm employees participated in a drawing contest with the theme “One star, one wish and lots of music following the festive dance of...

  Peania, March 4th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on February 28th 2019, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm SA's...

  Peania, March 7th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on March 4th 2019, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm SA's...

  Peania, March 14, 2019 - Lavipharm S.A., pursuant to article 17 of the European Parliament and Council Regulation 596/2014 (EU) and its Board of Directors meeting held on 11.03.2019, hereby notifies the investor community that it will participate to the share capital increase amounting to...

  Peania, February 9th, 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 07.02.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....

  Peania, June 15th, 2018 - The Ordinary Annual Shareholders Meeting of Lavipharm SA took place on Friday, June 15th, at the company's headquarters in Peania, with a 54.48% quorum. During the Shareholders’ Meeting, the management team presented all topics of the agenda along with the Annual...

  Peania, June 29th 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 28.06.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....

  Paiania, September 28, 2018 – Lavipharm demonstrated a solid performance in the first half of 2018. Despite the significant increase of obligatory rebates and clawbacks that burdened the pharma industry, Lavipharm sustained its Turnover and profitability, both at a consolidated and at parent company levels. More...